Sardocor, a subsidiary wholly-owned by Medera (www.linkedin.com/company/medera-biopharmaceutical), is dedicated to the clinical development of novel therapies.
Building upon Novoheart’s (www.linkedin.com/company/novoheart-limited) bioengineered human tissue-based assays for disease modelling and drug discovery, Sardocor aspires to create the shortest regulatory path to the clinic for advancing effective next-generation cell & gene therapy
Company Details
- Employees
- 6
- Address
- 6 Tide St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Boston, MA
Sardocor Questions
Sardocor's website is https://www.medera.bio/programs/#sardocor
Sardocor's LinkedIn profile is https://www.linkedin.com/company/sardocor
Sardocor has
6 employees.
View email and phone details for 6
employees at Sardocor.
Sardocor's industry is
Biotechnology Research
Sardocor's top competitors are
Xellera Therapeutics,
Carbon Biosciences,
Viage Therapeutics, Inc.,
Solid Biosciences,
Skin And Beauty Center,
Medera Inc.,
Vasorx, Inc.,
Novoheart,
Parallel Immunotherapeutics Inc.,
Capricor Therapeutics, Inc..
Sardocor's categories are Biotechnology Research
